U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
- 15/12/2024, 00:53
-
ansa.it
0
Scopri altro
- 15/02/2025, 00:53
-
ansa.it
-
0
- 14/02/2025, 22:42
-
ansa.it
-
0
- 14/02/2025, 22:40
-
ansa.it
-
0
- 14/02/2025, 20:56
-
ansa.it
-
0
- 14/02/2025, 20:38
-
ilfattoquotidiano.it
-
0
- 14/02/2025, 19:55
-
ansa.it
-
0
- 14/02/2025, 19:49
-
ansa.it
-
0
Nessun commento